New injection aims to shrink skin cancer tumors before removal
Disease control
Ongoing
This study is testing an experimental drug called BO-112, which is injected directly into basal cell carcinoma skin cancer tumors. The goal is to see if the injection can shrink or eliminate the tumors before they are surgically removed, and to check how safe it is. The trial wil…
Phase: PHASE2 • Sponsor: Highlight Therapeutics • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC